Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Danbury, Texas: The Complete Guide for Patients and Families

For many women in Danbury and across Brazoria County, the path to recovery after a mastectomy or the journey toward self-confidence following a breast procedure is supposed to be marked by healing and hope. Whether you were treated at a major specialized center in the Texas Medical Center or stayed closer to home at the UTMB Health Angleton Danbury Campus, you placed your trust in the medical devices implanted in your body. You trusted that the surgical mesh, the acellular dermal matrix (ADM), or the bioabsorbable scaffold reinforcement used to support your reconstruction or augmentation was thoroughly tested, FDA-approved, and safe for its intended use.

The reality that many patients in the Danbury area are now discovering is far more troubling. We have found that many of these products, including widely used brands like GalaFLEX and various acellular dermal matrices, were never formally approved by the FDA for use in breast surgery. Instead, they entered the market through a regulatory shortcut known as the 510(k) clearance pathway—a process that does not require the same rigorous clinical testing as a full Premarket Approval (PMA).

At The Manginello Law Firm, PLLC, operating under the brand Attorney911, we represent women who are now facing the physical, emotional, and financial consequences of these defective devices. Our Managing Partner, Ralph P. Manginello, has been licensed by the State Bar of Texas (Bar Card No. 24007597) for twenty-seven years and is admitted to the United States District Court for the Southern District of Texas—the very court where many Danbury-area product liability cases are heard. Together with Associate Attorney Lupe Peña (Bar Card No. 24084332), a third-generation Texan with deep family ties to the King Ranch and a native of nearby Sugar Land, we fight to hold multi-billion-dollar manufacturers accountable when their products fail the women they were meant to help.

If you are experiencing complications like chronic pain, persistent redness, fluid collection, or a devastating cancer diagnosis like BIA-ALCL, you are not alone. We are here to help you understand your rights and the complex regulatory failures that led to this crisis. You can reach us 24/7 at 1-888-ATTY-911 for a completely free and confidential consultation.

Why Danbury Patients Are at Risk: The Transition from Local Care to Regional Centers

Danbury is a close-knit community where neighbors look out for one another. While our city offers a quiet, peaceful lifestyle, major medical interventions—especially complex breast reconstructions following a cancer diagnosis—often take residents into the larger medical hubs of Southeast Texas. Whether your journey began with a diagnosis at a local clinic in Brazoria County or you were referred directly to specialists in Houston or Galveston, the devices used in your surgery are part of a global supply chain often plagued by inadequate oversight.

Many patients from the Danbury area undergo procedures involving “internal bra” techniques or acellular dermal matrix reinforcement. These procedures are frequently performed at regional referral centers where surgeons may have been influenced by aggressive manufacturer marketing for products that the FDA now explicitly warns have not been determined safe and effective for breast surgery.

We understand the unique geography of Brazoria County. We know that a woman in Danbury who experiences a complication—perhaps a sudden swelling or a persistent fever—often has to navigate the drive down Highway 35 or over to the Texas Medical Center for specialized revision surgery. This “treatment burden” is a significant part of the damages we pursue for our clients. We don’t just see a case file; we see a neighbor whose life has been upended by a manufacturer’s decision to prioritize market share over patient safety.

Understanding the Internal Scaffolding: ADM and Bioabsorbable Mesh

To understand your legal options, it is essential to understand what was placed in your body. In both reconstructive and aesthetic breast surgery, surgeons often use a “scaffold” to support the lower part of the breast or to cover an implant. This is sometimes called the “internal bra” technique.

Acellular Dermal Matrix (ADM)

ADM is a biologic material derived from human or animal skin. The cells are removed (decellularized), leaving behind a collagen framework that is supposed to allow your own tissue to grow into it.

• Human-derived brands: AlloDerm (Allergan/AbbVie), FlexHD (MTF Biologics), AlloMax (Becton Dickinson).
• Animal-derived brands: Strattice (porcine/pig), SurgiMend (bovine/cow).

Bioabsorbable and Synthetic Scaffolds

These are man-made materials designed to provide temporary support while your body heals, eventually dissolving over 12 to 24 months.

• GalaFLEX (Becton Dickinson/Galatea): Made from poly-4-hydroxybutyrate (P4HB).
• Phasix (Becton Dickinson/Davol): Also made from P4HB.
• DuraSorb (Integra LifeSciences): A polydioxanone (PDO) mesh.

The fundamental issue is that these materials, particularly the P4HB used in GalaFLEX, can cause severe immunological reactions, fail to dissolve as promised, or harbor bacterial endotoxins that lead to chronic inflammation. We focus on these technical failures because we know that generalist personal injury firms often miss the nuance of material science that proves a product was defectively designed.

The Regulatory Gap: How 510(k) Clearance Failed Danbury Women

A common misconception among patients in Danbury is that if a medical device is “FDA Cleared,” it means the FDA has verified it is safe for the specific surgery they underwent. Unfortunately, in the world of medical device law, “cleared” and “approved” mean very different things.

Most mesh and ADM products entered the market through the 510(k) pathway (21 USC §360c). This pathway only requires the manufacturer to show that their new device is “substantially equivalent” to a “predicate device” already on the market.

• The Predicate Creep: For example, the manufacturers of GalaFLEX cited a surgical suture as one of their predicates. They essentially argued that because a dissolvable stitch was safe, a large mesh sheet made of the same material was also safe.
• Off-Label Promotion: While surgeons are allowed to use devices “off-label” (using them for a purpose not specifically cleared by the FDA), manufacturers are strictly prohibited from marketing them for those uses.

On November 9, 2023, the FDA issued a landmark letter to healthcare providers, explicitly stating: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”

This letter, which named the entire GalaFLEX and Phasix product lines, is a critical piece of evidence. It suggests that for years, these companies knew—or should have known—that they were encouraging surgeons to use their products in ways that had never been scientifically validated. If you were a patient in Danbury who received one of these devices before these warnings were issued, your right to informed consent may have been compromised.

The Spectrum of Injury: What to Look For

Injury from defective mesh or ADM is not always immediate. Some complications arise within weeks, while others, like the rare cancers associated with textured implants, can take a decade to manifest. Residents of Danbury and Brazoria County should be vigilant for the following:

1. Reconstructive Failure and Infection

This is the most common acute complication. Acellular dermal matrices like FlexHD and AlloMax have been associated with significantly higher rates of infection and explantation. If you had to have your reconstruction abandoned or were left with a “flat closure” due to uncontrollable infection, the device may be to blame.

2. Red Breast Syndrome (RBS)

Unique to ADM, this is a non-infectious, sterile inflammation where the breast turns bright red. Research, including studies by Nguyen et al. (2019), suggests this is caused by endotoxins—bacterial remnants—that survive the sterilization process. Even though the product is “sterile,” these remnants trigger a massive host inflammatory response.

3. BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma)

This is a CD30-positive, ALK-negative T-cell lymphoma that develops in the scar tissue around an implant. It is strongly linked to textured-surface devices, particularly the recalled Allergan BIOCELL line. Symptoms usually include a sudden, asymmetric swelling (late seroma) between 7 and 10 years after surgery.

4. BIA-SCC (Breast Implant-Associated Squamous Cell Carcinoma)

A distinct epithelial tumor identified in implant capsules. In March 2023, the FDA updated its safety communication to reflect the emergence of this cancer, which can stay latent for 40 years before appearing.

5. Chronic Pain and “Bottoming Out”

Bioabsorbable scaffolds like GalaFLEX are supposed to provide support. When they degrade too quickly, the reconstruction can “bottom out” or lose its shape. Conversely, when they fail to degrade—as many patients report—they become a permanent, palpable foreign object that causes chronic neuropathic pain and intercostal neuralgia.

Why The Manginello Law Firm is the Right Choice for Danbury

When choosing an attorney for a medical device case, you need more than just a local lawyer; you need a firm with the structural capability to take on institutional giants.

We are currently lead counsel in Bermudez v. Pi Kappa Phi, a high-profile multi-defendant lawsuit filed in November 2025 where we are seeking $10,000,000 in damages. This case demonstrates our ability to litigate against multiple corporate and institutional entities simultaneously—the exact skill set required for a complex multidistrict litigation (MDL) involving device manufacturers, distributors, and healthcare systems.

The Advantage of Our Experience:

• Insurance Industry Insider: Lupe Peña brings a unique perspective to our firm. Her previous experience in insurance defense means we know exactly how the other side plans to lowball your claim. We anticipate their “blame the surgeon” or “pre-existing condition” arguments before they ever file them.
• Bilingual Representation: In Brazoria County, we know that many families speak Spanish at home. Lupe Peña is fluent and conducts full legal consultations in Spanish. You won’t have to talk through a translator; you will speak directly to your attorney in the language you are most comfortable with. Hablamos español y estamos listos para defender sus derechos.
• 27 Years of Continuous Practice: Ralph Manginello’s tenure in the Texas Bar and his membership in the Pro Bono College of the State Bar of Texas reflect a career dedicated to service and excellence. Our firm is rated 4.9 out of 5.0 on Birdeye across hundreds of reviews because we treat our clients like family.

The Whistleblower Evidence: What Becton Dickinson Knew

One of the most important developments for Danbury patients involves the testimony of Dr. Hooman Noorchashm. A cardiothoracic surgeon and former Medical Director at Becton Dickinson (BD), Dr. Noorchashm was reportedly terminated in 2022 after raising serious safety concerns about GalaFLEX.

Dr. Noorchashm has alleged that:

1. Breast cancer recurrences in GalaFLEX clinical trials were not properly reported to the FDA.
2. Hundreds of adverse event reports in the FDA’s MAUDE database lacked critical details about patient harm.
3. The company engaged in aggressive off-label marketing, treating American women like “human subjects” in a massive unauthorized experiment.

If your case involves GalaFLEX or Phasix, this whistleblower record is central to proving that the manufacturer prioritized profit over the safety of women in communities like Danbury.

Legal Deadlines and the “Discovery Rule” in Texas

Time is a critical factor in any device injury case. In Texas, the general statute of limitations for product liability is two years. However, for many Danbury women, the “Discovery Rule” is vital. This rule can stay the clock until the date you discovered—or reasonably should have discovered—that your injuries were caused by the defective mesh or ADM.

For many, that “discovery date” might be the day the FDA issued its 2023 warning letter, or the day a second-opinion surgeon pointed to the mesh as the source of chronic infection. Because these laws are complex and involve a 15-year statute of repose (an absolute cutoff from the date of first sale), you should not wait to seek legal advice.

How to Get Started: Steps for Danbury Residents

If you suspect your breast reconstruction or augmentation failed due to defective materials, we recommend taking these immediate steps:

1. Secure Your Operative Reports: Request the “long-form” operative notes and “device implant logs” from the hospital or surgical center where you were treated. These will contain the Unique Device Identifier (UDI) stickers with the brand, model, and lot number of everything used.
2. Preserve the Evidence: If you are undergoing a revision or explant surgery, tell your surgeon and the pathology lab that you want the removed mesh or ADM preserved. This is your physical evidence.
3. Document Your Journey: Keep a journal of your symptoms, photographs of visible inflammation, and a record of every doctor’s visit and out-of-pocket expense.
4. Call Attorney911: We offer a free, no-obligation consultation. We will review your records, determine the manufacturer, and explain the realistic path forward through the current litigation landscape, including the Allergan BIOCELL MDL 2921 or individual state-court filings.

Frequently Asked Questions for Danbury Patients

Is breast mesh actually illegal?
No, but it is “off-label.” The FDA has not cleared these products specifically for breast reconstruction. Using them is at the surgeon’s discretion, but marketing them for that use by the manufacturer is where the liability often lies.

What if my surgery was at UTMB or in Lake Jackson? Can I still sue a manufacturer?
Yes. Your case is against the company that designed and sold a defective product, regardless of where the surgery was performed. Our firm is admitted to the Southern District of Texas, which covers Brazoria County, and we handle cases across the entire state.

I don’t have cancer, but my mesh is painful. Do I have a case?
Absolutely. Many of our clients suffer from severe inflammatory reactions, chronic pain, and permanent disfigurement. You do not need a cancer diagnosis to seek compensation for a defective medical device.

What does it cost to hire your firm?
We work on a contingency fee basis. This means we pay for all the experts, the filing fees, and the investigative costs. You pay us nothing unless we recover compensation for you.

Your Path to Justice in Brazoria County

We know the women of Danbury are resilient. We know that after fighting through a breast cancer diagnosis or a difficult recovery, the last thing you want is a legal battle. But the companies that put these devices on the market have billions of dollars set aside to defend themselves; you deserve someone in your corner who is just as prepared.

At The Manginello Law Firm, we combine the technical authority of medical device specialists with the personal touch of a Texas-native team. We are your neighbors, we are your advocates, and we are ready to listen to your story.

Call us today at 1-888-ATTY-911 (1-888-288-9911). Whether you are at home in Danbury, in a recovery room in Angleton, or seeking a second opinion in Houston, we are here for you. No cost. No obligation. Just the truth about what happened to you and how we can make it right.

Attorney Advertising. Past results do not guarantee future outcomes. The Manginello Law Firm, PLLC is headquartered at 1177 West Loop South, Suite 1600, Houston, TX 77027. Ralph P. Manginello is the attorney responsible for this content.